Inception of the metastatic phenotype by macrophage-cancer cell fusion.
Summary
It is now well-established that patient outcome are good if the primary tumor has not
spread; can be surgically removed; treated locally with radiation; or preventive
chemotherapy can be applied. In contrast, when cancer cells have disseminated, the
mortality rates increase significantly and therapeutic treatment strategies are eventually
switched from curative to palliative. Although responsible for the majority of cancer
deaths, knowledge about the emergence of metastatic cells remains scarce. Nevertheless,
in vivo evidence in animal models and humans is accumulating and supportive of the
century-old macrophage-cancer cell fusion theory. The theory implies that the metastatic
cells emerge from a fusion event and express the phenotypes of the migratory
macrophage and the proliferative cancer cell. Although the theory is steadily gaining
approval from cancer researchers, it still lacks essential attention from the broader
research community. We will review the current knowledge surrounding the
macrophage-cancer cell fusion theory. It is our believe that work on the fusion theory and
in the research fields related to it will enhance our understanding of metastasis, and
ultimately lead to the development of novel and effective strategies for the treatment of
metastatic cancers.